Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Optimization Regarding Anticholinergic Medications Potential Impact on Cognitive Test Performance

NCT03208569 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT03208569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03208569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Optimization Regarding Anticholinergic Medications Potential Impact on Cognitive Test Performance
Lead sponsor
Region Skane
Phase
Observational
Overall status
Completed
Start date
September 1, 2017
Completion date
September 30, 2021
Enrollment
663 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticholinergics, cognitive function